Hjem › Wilms tumor › Tennessee
Kliniske studier for Wilms tumor i Tennessee
6 studier for Wilms tumor søker deltakere på steder i Tennessee.
Byer i Tennessee
Offisiell studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Saint Jude Children's Research Hospital, Memphis
RekruttererFase 2
Alder 12 til 39 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- og 1 flere
RekruttererFase 2
Opp til 30 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Saint Jude Children's Research Hospital, Memphis
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- St. Jude Children's Research Hospital, Memphis
RekruttererFase 1
Opp til 21 år · Alle kjønn · Oppdatert 19. mai 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- St. Jude Children's Research Hospital, Memphis
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 19. mai 2026 · NCT04901702Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
- St.Jude Children's Research Hospital, Memphis
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT04968990Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.